We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
3726
DELISTED
Asensus Surgical, Inc.
ASXC
$27K ﹤0.01%
54,400
-75,573
-58% -$45.2K
CPTN
3727
DELISTED
Cepton, Inc. Common Stock
CPTN
$27K ﹤0.01%
+5,616
New +$24.6K
BFRI icon
3728
Biofrontera
BFRI
$15M
$26K ﹤0.01%
2,522
+735
+41% +$7.8K
ELEV
3729
DELISTED
Elevation Oncology
ELEV
$26K ﹤0.01%
16,800
-34,700
-67% -$91.5K
ZKIN icon
3730
ZK International Group
ZKIN
$77.4M
$26K ﹤0.01%
4,981
-2,219
-31% -$10.8K
TLIS
3731
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$26K ﹤0.01%
3,660
+827
+29% +$6K
CREG
3732
DELISTED
Smart Powerr
CREG
$25K ﹤0.01%
156
+5
+3% +$862
IVVD icon
3733
Invivyd
IVVD
$158M
$25K ﹤0.01%
24,200
+3,700
+18% +$4.72K
SCKT icon
3734
Socket Mobile
SCKT
$3.32M
$25K ﹤0.01%
17,500
+1,800
+11% +$2.77K
YGMZ
3735
DELISTED
MingZhu Logistics Holdings
YGMZ
$25K ﹤0.01%
220
-133
-38% -$19K
KBNT
3736
DELISTED
Kubient, Inc. Common Stock
KBNT
$25K ﹤0.01%
44,896
+3,400
+8% +$2.05K
CLPS icon
3737
CLPS Inc
CLPS
$25.6M
$24K ﹤0.01%
20,232
-8,300
-29% -$9.95K
MAIA icon
3738
MAIA Biotechnology
MAIA
$76M
$24K ﹤0.01%
10,800
-9,850
-48% -$26.3K
MNDO icon
3739
Mind CTI
MNDO
$19.4M
$24K ﹤0.01%
12,105
-17,695
-59% -$34.5K
RETO icon
3740
ReTo Eco-Solutions
RETO
$23.5M
$24K ﹤0.01%
11
+10
+1,000% +$274K
RVSN icon
3741
Rail Vision
RVSN
$8.79M
$24K ﹤0.01%
+192
New +$36.2K
SNOA icon
3742
Sonoma Pharmaceuticals
SNOA
$5.26M
$24K ﹤0.01%
1,110
-988
-47% -$20.3K
NURO
3743
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$24K ﹤0.01%
3,015
-1,670
-36% -$15.4K
NBSE
3744
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$24K ﹤0.01%
12,601
+3,970
+46% +$13.1K
FXLV
3745
DELISTED
F45 Training Holdings Inc.
FXLV
$24K ﹤0.01%
47,600
-15,374
-24% -$13.1K
PCSA icon
3746
Processa Pharmaceuticals
PCSA
$5.95M
$23K ﹤0.01%
91
+29
+47% +$8.57K
TOMZ icon
3747
TOMI Environmental Solutions
TOMZ
$12.3M
$23K ﹤0.01%
11,581
-3,586
-24% -$7.24K
UPXI icon
3748
Upexi
UPXI
$55.5M
$23K ﹤0.01%
500
-165
-25% -$11.3K
WATT icon
3749
Energous
WATT
$77.6M
$23K ﹤0.01%
+161
New +$34.4K
STAF
3750
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$23K ﹤0.01%
+3,570
New +$38.9K

Similar funds

Renaissance Technologies's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.

  • Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
  • Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
  • Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.